NL7203536A - - Google Patents

Info

Publication number
NL7203536A
NL7203536A NL7203536A NL7203536A NL7203536A NL 7203536 A NL7203536 A NL 7203536A NL 7203536 A NL7203536 A NL 7203536A NL 7203536 A NL7203536 A NL 7203536A NL 7203536 A NL7203536 A NL 7203536A
Authority
NL
Netherlands
Application number
NL7203536A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7203536A publication Critical patent/NL7203536A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • C07D243/28—Preparation including building-up the benzodiazepine skeleton from compounds containing no hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/006—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length of peptides containing derivatised side chain amino acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NL7203536A 1971-03-17 1972-03-16 NL7203536A (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH386871A CH554349A (de) 1971-03-17 1971-03-17 Verfahren zur herstellung von optisch aktiven 1,3-dihydro-2h-1,4-benzodiazepin-2-onen.

Publications (1)

Publication Number Publication Date
NL7203536A true NL7203536A (cg-RX-API-DMAC7.html) 1972-09-19

Family

ID=4265209

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7203536A NL7203536A (cg-RX-API-DMAC7.html) 1971-03-17 1972-03-16

Country Status (16)

Country Link
AT (1) AT327909B (cg-RX-API-DMAC7.html)
BE (1) BE780892A (cg-RX-API-DMAC7.html)
CA (1) CA992079A (cg-RX-API-DMAC7.html)
CH (1) CH554349A (cg-RX-API-DMAC7.html)
DE (1) DE2212526A1 (cg-RX-API-DMAC7.html)
ES (1) ES400851A1 (cg-RX-API-DMAC7.html)
FR (1) FR2130342B1 (cg-RX-API-DMAC7.html)
GB (2) GB1391081A (cg-RX-API-DMAC7.html)
HU (1) HU165496B (cg-RX-API-DMAC7.html)
IL (2) IL38991A (cg-RX-API-DMAC7.html)
NL (1) NL7203536A (cg-RX-API-DMAC7.html)
NO (1) NO137896C (cg-RX-API-DMAC7.html)
SE (1) SE399887B (cg-RX-API-DMAC7.html)
SU (1) SU453842A3 (cg-RX-API-DMAC7.html)
YU (1) YU34882B (cg-RX-API-DMAC7.html)
ZA (1) ZA721845B (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH602672A5 (cg-RX-API-DMAC7.html) * 1974-06-28 1978-07-31 Hoffmann La Roche
CH603655A5 (cg-RX-API-DMAC7.html) * 1974-10-21 1978-08-31 Hoffmann La Roche
AU6420700A (en) * 1999-08-05 2001-03-05 Prescient Neuropharma Inc. Novel 1,4-benzodiazepine compounds and derivatives thereof

Also Published As

Publication number Publication date
YU69772A (en) 1979-10-31
YU34882B (en) 1980-04-30
ES400851A1 (es) 1975-01-16
SU453842A3 (cg-RX-API-DMAC7.html) 1974-12-15
GB1391081A (en) 1975-04-16
GB1391082A (en) 1975-04-16
FR2130342B1 (cg-RX-API-DMAC7.html) 1977-01-14
SE399887B (sv) 1978-03-06
FR2130342A1 (cg-RX-API-DMAC7.html) 1972-11-03
NO137896C (no) 1978-05-16
CA992079A (en) 1976-06-29
NO137896B (no) 1978-02-06
IL38991A (en) 1976-09-30
CH554349A (de) 1974-09-30
DE2212526A1 (de) 1972-09-21
ATA214972A (de) 1975-05-15
IL47123A (en) 1976-09-30
IL38991A0 (en) 1972-05-30
AT327909B (de) 1976-02-25
BE780892A (fr) 1972-07-17
HU165496B (cg-RX-API-DMAC7.html) 1974-09-28
ZA721845B (en) 1972-12-27

Similar Documents

Publication Publication Date Title
DK133549C (cg-RX-API-DMAC7.html)
DE2132124B2 (cg-RX-API-DMAC7.html)
FR2090537A5 (cg-RX-API-DMAC7.html)
DE2203415C3 (cg-RX-API-DMAC7.html)
FR2122153A5 (cg-RX-API-DMAC7.html)
FR2121038A5 (cg-RX-API-DMAC7.html)
DK138748C (cg-RX-API-DMAC7.html)
DE2125158A1 (cg-RX-API-DMAC7.html)
DE2132404C3 (cg-RX-API-DMAC7.html)
FR2130342A1 (cg-RX-API-DMAC7.html)
CS156169B1 (cg-RX-API-DMAC7.html)
DE2162100B2 (cg-RX-API-DMAC7.html)
FI47629B (cg-RX-API-DMAC7.html)
FI51895B (cg-RX-API-DMAC7.html)
FR2121396A1 (cg-RX-API-DMAC7.html)
FR2081722B1 (cg-RX-API-DMAC7.html)
FR2122344B2 (cg-RX-API-DMAC7.html)
CS161667B2 (cg-RX-API-DMAC7.html)
FR2118131B1 (cg-RX-API-DMAC7.html)
AU451756B2 (cg-RX-API-DMAC7.html)
CS150795B1 (cg-RX-API-DMAC7.html)
DE2134281A1 (cg-RX-API-DMAC7.html)
CS176388B1 (cg-RX-API-DMAC7.html)
CS154976B1 (cg-RX-API-DMAC7.html)
CS171833B1 (cg-RX-API-DMAC7.html)